Association Between Vericiguat and Clinical Outcomes Across Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Heart failure (HF) remains a major global health burden, with mortality continuing to rise despite therapeutic advances. Vericiguat, a soluble guanylate cyclase stimulator, has demonstrated potential benefit in patients with worsening HF with reduced ejection fraction...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
IMR Press
2026-04-01
|
| Col·lecció: | Reviews in Cardiovascular Medicine |
| Matèries: | |
| Accés en línia: | https://www.imrpress.com/journal/RCM/27/4/10.31083/RCM49095 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|